Evogene (EVGN) Reports Q3 Loss of $0.57/Share

Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.57), versus ($0.51) reported last year. Revenue for the quarter came in at $2.65 million, versus $5.36 million reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
• Morgan Stanley upgrades CDW on stronger AI-driven server demand